MassBio Announces New Collaborations with Nature Publishing Group & Journal of Commercial Biotechnology
CAMBRIDGE, MA (August 21, 2014) – MassBio members can now save on leading scientific journals through new partnerships with Nature Publishing Group (NPG) and the Journal of Commercial Biotechnology announced today.
By joining the already robust MassBio Purchasing Consortium, Nature Publishing Group (NPG) has committed to offering select MassBio members special pricing on NPG’s Articles on Demand Platform and reduced site license pricing for the journals Nature and Nature Biotechnology. MassBio’s partnership with NPG is specifically designed to support small biotechs, hospitals, non-profits, and associate members of MassBio. NPG publishes high-impact peer-reviewed research in all fields of science along with news and commentary on trends affecting science, scientists and the wider public.
The Journal of Commercial Biotechnology will offer new MassBio members a free one-year digital institutional subscription and existing MassBio members discounts off personal or institutional subscriptions. The journal publishes peer-reviewed, authoritative, cutting-edge articles written by the leading practitioners and researchers in the field, addressing topics such as management, policy, finance, law, regulation, and bioethics.
“Access to leading scientific journals is critical but sometimes prohibitively expensive for our small member companies,” said Robert K. Coughlin, President & CEO of MassBio. “We are thrilled to help our members access articles from and subscriptions to Nature, Nature Biotechnology, and the Journal of Commercial Biotechnology at a discount through these new partnerships.”
“We are extremely excited to be partnering with MassBio to offer our world class content to organizations in a position to make a difference in the pursuit of scientific discovery,” said Elliot Hermann, Vice President, Sales Operations & Analysis of NPG. “This partnership very much fits within our core values of promoting scientific knowledge to the widest possible audience.”
The MassBio Purchasing Consortium aggregates the purchasing power of MassBio member companies to negotiate contracts with vendors that create significant savings for members. Current contracts include lab supplies and equipment, equipment maintenance, hazardous and biomedical waste removal, packaged and bulk gases, office supplies and furniture, travel management, auto insurance, domestic and international shipping, mobile solutions, and scientific journals.
Contract highlights are available online at www.massbio.org.
MassBio, a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry, is the nation's oldest biotechnology trade association. Founded in 1985, MassBio is committed to advancing the development of critical new science, technology and medicines that benefit people worldwide. Representing 650 biotechnology companies, academic institutions, research hospitals, and service organizations involved in life sciences and health care, MassBio works to advance policy and promote education, while providing member programs and events, industry information, and services.
About Nature Publishing Group
Nature Publishing Group (NPG) is a publisher of high impact scientific information in print and online. NPG publishes journals, online databases and services across the life, physical, chemical and applied sciences.
Focusing on the needs of scientists, Nature (founded in 1869) is the leading weekly, international scientific journal. NPG publishes a range of Nature research journals and Nature Reviews journals, and a range of prestigious academic and partner journals including society-owned publications. Online, nature.com provides over 8 million visitors per month with access to NPG publications and services, including news and comment from Nature, and the leading scientific jobs board Naturejobs.
About the Journal of Commercial Biotechnology
The Journal of Commercial Biotechnology, in print since 1994, is the definitive international quarterly publication for bioscience business professionals. The journal is designed specifically for those professionals who need to enhance their knowledge of biotechnology business strategy and management, improve and advance their product development or want to keep up to date with current issues and industry trends